Fidelity Investments
LPCN icon

Fidelity Investments’s Lipocine LPCN Stock Holding History

Fidelity Investments’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5K Buy
626
+549
+713% +$4.78K ﹤0.01% 4916
2025
Q4 		$618 Buy
77
+18
+31% +$61 ﹤0.01% 5138
2025
Q3 		$169 Buy
+59
New +$179 ﹤0.01% 5166
2025
Q2 		– Sell
-237
Closed -$754 – 5424
2025
Q1 		$754 Buy
237
+172
+265% +$666 ﹤0.01% 4985
2024
Q4 		$317 Buy
+65
New +$330 ﹤0.01% 5028
2024
Q1 		– Sell
-90
Closed -$248 – 5572
2023
Q4 		$248 Buy
90
+31
+53% +$82 ﹤0.01% 4867
2023
Q3 		$173 Buy
59
+50
+556% +$210 ﹤0.01% 4803
2023
Q2 		$45 Buy
+9
New +$42 ﹤0.01% 5034
2022
Q3 		– Sell
-6
Closed – – 5198
2022
Q2 		$0 Sell
6
-2
-25% -$31 ﹤0.01% 5256
2022
Q1 		$0 Sell
8
-3
-27% -$63 ﹤0.01% 5269
2021
Q4 		$0 Hold
11
– – ﹤0.01% 4701
2021
Q3 		$0 Buy
+11
New +$243 ﹤0.01% 4744
2021
Q2 		– Hold
0
– – – 4614

Other funds holding LPCN

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $318M AUM
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Fidelity Investments's LPCN Position: Q1 2026 in Review

Fidelity Investments increased its Lipocine (LPCN) stake by 713% in Q1 2026, buying an estimated $4.78K and bringing the position to 626 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #4916.

Fidelity Investments first reported a position in LPCN in Q3 2021 and has held it in 12 quarters since. 47 funds tracked by Wall St. Rank hold LPCN as of Q1 2026.

  • Fidelity Investments held 626 shares of Lipocine worth $5K as of Q1 2026.
  • Fidelity Investments bought 549 Lipocine shares in Q1 2026, an estimated $4.78K.
  • Lipocine made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4916 holding.
  • Fidelity Investments first reported a position in Lipocine in Q3 2021 and has held it in 12 quarters since.
  • 47 funds tracked by Wall St. Rank held Lipocine as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.